Short Interest in The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Grows By 216.2%

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 23,400 shares, a growth of 216.2% from the December 31st total of 7,400 shares. Based on an average trading volume of 28,300 shares, the days-to-cover ratio is currently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Shares of NASDAQ CGABL traded up $0.26 during mid-day trading on Thursday, reaching $18.96. 19,651 shares of the company’s stock were exchanged, compared to its average volume of 25,050. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52-week low of $17.48 and a 52-week high of $20.85. The company’s 50-day moving average is $18.55 and its 200-day moving average is $19.15.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Saturday, February 15th. Investors of record on Saturday, February 1st will be issued a dividend of $0.2891 per share. This represents a $1.16 dividend on an annualized basis and a yield of 6.10%. This is a boost from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. The ex-dividend date is Friday, January 31st.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.